B-CELL LYMPHOMA RECURRENT

This adverse event was reported 543 times

These drugs are most commonly taken by patients reporting B-CELL LYMPHOMA RECURRENT:

# Drug Count
0 RITUXIMAB 327
1 PREDNISONE 261
2 DOXORUBICIN 246
3 CYCLOPHOSPHAMIDE 231
4 CYCLOPHOSPHAMIDE FOR INJECTION 231
5 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 231
6 ETOPOSIDE 95
7 DEXAMETHASONE 86
8 DEXAMETHASONE 1.5 MG 86
9 CYTARABINE 72
See all common drugs associated with B-CELL LYMPHOMA RECURRENT

B-CELL LYMPHOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CARMUSTINE 24 0.0051
1 BENDAMUSTINE HCL 70 0.0045
2 IBRITUMOMAB TIUXETAN 6 0.0039
3 FLUDEOXYGLUCOSE F-18 1 0.0035
4 AXICABTAGENE CILOLEUCEL 29 0.0029
5 TOLCAPONE 1 0.0028
6 DOXORUBICIN 246 0.0027
7 MOSUNETUZUMAB 3 0.0027
8 ETOPOSIDE PHOSPHATE 4 0.0024
9 GRANULOCYTE COLONY STIMULATING FACTOR 5 0.0023
See all drugs enriched for association with B-CELL LYMPHOMA RECURRENT